GLP-2 compounds, formulations, and uses thereof
US7411039B2 · kind B2 · utility
67Cited by
15References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2003 |
| Grant date | Aug 12, 2008 |
| Priority date | — |
| Expiry date | Feb 4, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.